NCT01202630 - BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile Infection | Biotech Hunter

Enrollment

140

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

Recurrent Clostridium Difficile Infection

Interventions

DIETARY_SUPPLEMENT

Lactobacillus acidophilus CL1285® and Lactobacillus casei

2 capsules of Lactobacillus acidophilus CL1285® and Lactobacillus casei (50 billion cfu/capsule), consumed once daily for 60 days

DIETARY_SUPPLEMENT

Placebo

2 capsules of placebo (no live cells), consumed once daily for 60 days

Trial Locations (1)

Parker Jewish Institute, New Hyde Park